Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs magnesium sulfate vs esmolol for controlled hypotension during craniotomy after head injury
IRCT20141209020258N86Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) comparing Dexmedetomidine arm, Esmolol arm and Magnesium sulfate arm (3 arms). Primary endpoints: heart rate, blood pressure and 1 more. Started Feb 2018; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfateesmolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20141209020258N86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N86.